Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Chronic Lymphocytic Leukemia Overview

  • The Center for Chronic Lymphocytic Leukemia (CLL) at Dana-Farber Brigham Cancer Center provides comprehensive care and promising new therapies to patients with CLL.

    As one of only a few dedicated CLL centers in the country, our team has unique expertise in caring for patients with CLL, including extensive prognostic testing, tissue banking, and access to cellular therapies including stem cell/bone marrow transplant program and CAR T-cell therapy, if necessary.

    We are a centralized hub for CLL research. Our team of laboratory and clinical-based investigators and physicians offers access to clinical trials of new, promising therapies. Our goal is to have a clinical trial option for patients at every stage of the disease. We offer clinical trials for newly-diagnosed CLL, relapsed/refractory CLL, as well as Richter's syndrome, a condition where CLL turns into an aggressive form of lymphoma.

    Our Center is part of the Center for Hematologic Oncology at Dana-Farber Brigham Cancer Center, one of the world's largest and most respected treatment centers for patients with disorders of the blood or bone marrow.

    Exceptional Care for Patients with Chronic Lymphocytic Leukemia

    • Comprehensive evaluation and diagnosis, personalized treatment plans, and options for conventional and innovative treatments.
    • Access to the latest diagnostics, such as molecular and genomic profiling, including the Rapid Heme Panel, which was developed by our scientists to rapidly detect key mutations that are important for developing timely treatment plans.
    • Clinical trials evaluating new therapies for every stage of disease, including investigator-led studies informed by our clinical experience.
    • The full expertise of two renowned medical centers: Dana-Farber Cancer Institute and Brigham and Women's Hospital.
    • Care plans tailored to the needs of each patient, from the first meeting through long-term treatment planning and management.
    • Consultations and second opinions for patients and physicians around the world.
    • Physician-scientists who are not only part of the care team, but who also work in our labs to bring new and more effective treatments to patients quickly.
    • Treatment plans for initial therapy and relapsed disease, as well as expertise in cellular therapies such as stem cell/bone marrow transplant or CAR T-cell therapies for appropriate patients.
    • A treatment plan developed by a multidisciplinary team that works closely together to ensure that every approach is considered.
    • Comprehensive support services for you and your family.

    We Treat You, Not Just Your Cancer

    Our entire team is here to support you throughout treatment and during recovery. You and your family have access to our full range of support services and survivorship programs to help you live well beyond cancer.